1.Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?
Hwoe Gyeong OK ; Su Young KIM ; Su Jung LEE ; Tae Kyun KIM ; Billy K HUH ; Kyung Hoon KIM
The Korean Journal of Pain 2018;31(2):73-79
		                        		
		                        			
		                        			All drugs have both favorable therapeutic and untoward adverse effects. Conventional opioid analgesics possess both analgesia and adverse reactions, such as nausea, vomiting, and respiratory depression. The opioid ligand binds to µ opioid receptor and non-selectively activates two intracellular signaling pathways: the G protein pathway induce analgesia, while the β-arrestin pathway is responsible for the opioid-related adverse reactions. An ideal opioid should activate the G protein pathway while deactivating the β-arrestin pathway. Oliceridine (TRV130) has a novel characteristic mechanism on the action of the µ receptor G protein pathway selective (µ-GPS) modulation. Even though adverse reactions (ADRs) are significantly attenuated, while the analgesic effect is augmented, the some residual ADRs persist. Consequently, a G protein biased µ opioid ligand, oliceridine, improves the therapeutic index owing to increased analgesia with decreased adverse events. This review article provides a brief history, mechanism of action, pharmacokinetics, pharmacodynamics, and ADRs of oliceridine.
		                        		
		                        		
		                        		
		                        			Analgesia
		                        			;
		                        		
		                        			Analgesics, Opioid
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Bias (Epidemiology)
		                        			;
		                        		
		                        			Drug-Related Side Effects and Adverse Reactions
		                        			;
		                        		
		                        			GTP-Binding Proteins
		                        			;
		                        		
		                        			Intracellular Signaling Peptides and Proteins
		                        			;
		                        		
		                        			Ligands
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Knockout
		                        			;
		                        		
		                        			Nausea
		                        			;
		                        		
		                        			Patient Safety
		                        			;
		                        		
		                        			Pharmacokinetics
		                        			;
		                        		
		                        			Receptors, Opioid
		                        			;
		                        		
		                        			Receptors, Opioid, mu
		                        			;
		                        		
		                        			Respiratory Insufficiency
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
2.Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.
Min Soo KIM ; Jeong Rim LEE ; Eun Mi CHOI ; Eun Ho KIM ; Seung Ho CHOI
Yonsei Medical Journal 2015;56(5):1415-1420
		                        		
		                        			
		                        			PURPOSE: Postoperative nausea and vomiting (PONV) is a common problem after general anesthesia. Although 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have significantly reduced PONV, over 35% of patients treated with ondansetron can experience PONV. In this study, we investigated whether the Y129S and -100_-102AAG deletion polymorphisms of the 5-HT3B receptor gene affect the efficacy of ondansetron in preventing PONV. MATERIALS AND METHODS: Two hundred and forty-five adult patients who underwent laparoscopic cholecystectomy were enrolled. Ondansetron 0.1 mg/kg was intravenously administered 30 minutes before the end of surgery. Genomic DNA was prepared from blood samples using a nucleic acid isolation device. Both the Y129S variant and the -100_-102AAG deletion variant were screened for using a single base primer extension assay and a DNA direct sequencing method, respectively. The relationship between genetic polymorphisms and clinical outcomes of ondansetron treatment was investigated. RESULTS: Among the 5-HT3B AAG deletion genotypes, the incidence of PONV was higher in patients with the homomutant than with other genotypes during the first 2 hours after surgery (p=0.02). There were no significant differences in the incidence of PONV among genotypes at 2-24 hours after surgery. In the Y129S variants of the 5-HT3B receptor gene, there were no significant differences in the incidence of PONV among genotypes during the first 2 hours and at 2-24 hours after surgery. CONCLUSION: The response to ondansetron for PONV was significantly influenced by the -100_-102AAG deletion polymorphisms of the 5-HT3B gene. Thus, the -100_-102AAG deletion variants may be a pharmacogenetic predictor for responsiveness to ondansetron for PONV.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Anesthesia, General
		                        			;
		                        		
		                        			Antiemetics/administration & dosage/*pharmacology
		                        			;
		                        		
		                        			Cholecystectomy, Laparoscopic
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Genome, Human
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Injections, Intravenous
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Ondansetron/administration & dosage/*pharmacology
		                        			;
		                        		
		                        			Polymorphism, Genetic
		                        			;
		                        		
		                        			Postoperative Nausea and Vomiting/chemically induced/*drug therapy/epidemiology
		                        			;
		                        		
		                        			Receptors, Serotonin, 5-HT3/*drug effects/*genetics
		                        			;
		                        		
		                        			Time Factors
		                        			
		                        		
		                        	
3.Screening for prodromes of chemotherapy-induced vomiting and correlation between prodromes and chemotherapy-induced vomiting in lung cancer patients.
Jiuqin LU ; Liangliang MA ; Xinyue WANG ; Zhujun LIU ; Jing WANG ; Kai LI
Chinese Journal of Oncology 2014;36(7):511-515
OBJECTIVETo explore prodromes of chemotherapy-induced vomiting (CIV) and their association with CIV in lung cancer patients.
METHODSThe prodromes of CIV in 250 lung cancer patients were analyzed. Logistic regression was used to determine the symptoms most likely correlated with CIV. One hundred fifty-seven patients received medical interventions. The development of correlative symptoms and occurrence of CIV between the intervention and non-intervention groups was analyzed.
RESULTSAmong the 250 patients with the prodromes of CIV, the incidence rate of CIV was 67.2%. Logistic regression indicated that nausea, constipation, insomnia, hiccups, anorexia, and history of drinking were correlated with CIV (P < 0.05 for all). Among the 20 symptoms observed in this study, the incidence rates of relatively common symptoms were nausea (72.0%), anorexia (68.4%), taste changes (48.8%), constipation (45.6%), abdominal distension (45.6%), stomach distension(40.4%), and insomnia (40.0%). The incidence rats of all symptoms except hiccups before and after intervention had significant difference (P < 0.05 for all). The incidence rates of CIV were 30.0% in the intervention group and 50.6% in the non-intervention group, with a significant difference between the two groups (P = 0.009).
CONCLUSIONSProdromes of CIV are closely related to the occurrence of CIV. Timely intervention for prodromes of CIV can reduce the incidence rate of CIV during chemotherapy in lung cancer patients.
Animals ; Antineoplastic Agents ; adverse effects ; Humans ; Lung Neoplasms ; epidemiology ; Nausea ; chemically induced ; diagnosis ; epidemiology ; Rats ; Vomiting ; chemically induced ; diagnosis ; epidemiology
4.Incidence and Risk Factors of Postoperative Nausea and Vomiting in Patients with Fentanyl-Based Intravenous Patient-Controlled Analgesia and Single Antiemetic Prophylaxis.
Jong Bum CHOI ; Yon Hee SHIM ; Youn Woo LEE ; Jeong Soo LEE ; Jong Rim CHOI ; Chul Ho CHANG
Yonsei Medical Journal 2014;55(5):1430-1435
		                        		
		                        			
		                        			PURPOSE: We evaluated the incidence and risk factors of postoperative nausea and vomiting (PONV) in patients with fentanyl-based intravenous patient-controlled analgesia (IV-PCA) and single antiemetic prophylaxis of 5-hydroxytryptamine type 3 (5 HT3)-receptor antagonist after the general anesthesia. MATERIALS AND METHODS: In this retrospective study, incidence and risk factors for PONV were evaluated with fentanyl IV-PCA during postoperative 48 hours after various surgeries. RESULTS: Four hundred-forty patients (23%) of 1878 had showed PONV. PCA was discontinued temporarily in 268 patients (14%), mostly due to PONV (88% of 268 patients). In multivariate analysis, female, non-smoker, history of motion sickness or PONV, long duration of anesthesia (>180 min), use of desflurane and intraoperative remifentanil infusion were independent risk factors for PONV. If one, two, three, four, five, or six of these risk factors were present, the incidences of PONV were 18%, 19%, 22%, 31%, 42%, or 50%. Laparoscopic surgery and higher dose of fentanyl were not risk factors for PONV. CONCLUSION: Despite antiemetic prophylaxis with 5 HT3-receptor antagonist, 23% of patients with fentanyl-based IV-PCA after general anesthesia showed PONV. Long duration of anesthesia and use of desflurane were identified as risk factors, in addition to risk factors of Apfel's score (female, non-smoker, history of motion sickness or PONV). Also, intraoperative remifentanil infusion was risk factor independent of postoperative opioid use. As the incidence of PONV was up to 50% according to the number of risk factors, risk-adapted, multimodal or combination therapy should be applied.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Analgesia, Patient-Controlled/*adverse effects
		                        			;
		                        		
		                        			Analgesics, Opioid/*adverse effects/therapeutic use
		                        			;
		                        		
		                        			Antiemetics/administration & dosage/therapeutic use
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fentanyl/*adverse effects/therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Isoflurane/adverse effects/*analogs & derivatives/therapeutic use
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Piperidines/*adverse effects/therapeutic use
		                        			;
		                        		
		                        			Postoperative Nausea and Vomiting/chemically induced/*epidemiology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Risk Factors
		                        			
		                        		
		                        	
5.Adverse Effect of Newer Antidepressant ; Nausea and Vomiting, Weight Gain, Sexual Dysfunction: Mechanisms, Epidemiology, and Pharmacological Management.
Korean Journal of Psychosomatic Medicine 2013;21(2):81-92
		                        		
		                        			
		                        			Newer antidepressants are commonly used in clinical practice to treat psychiatric disorder and psychosomatic disorder including chronic pain syndrome, fibromyalgia, headache. However there are many unexpected adverse effects of these drugs such as nausea and vomiting, weight gain, sexual dysfunction. These are 3 most well-recognized common adverse effects of newer antidepressant and are most common causes of treatment failure. I reviewed mechanisms, epidemiology, and pharmacological management of these adverse effects of newer antidepressants. In this paper, newer antidepressants include selective serotonin reuptake inhibitor(fluoxetine, fluvoxamine, citalopram, escitalopram, sertraline, paroxetine), serotonin norepinephrine reuptake inhibitor(venlafaxine, duloxetine), norepinephrine and dopamine reuptake inhibitor(bupropion), noradrenergic and specific serotonergic antidepressant(mirtazapine), and reversible inhibitor of MAO-A(moclobemide). I suggest that psychiatrists and clinicians in the psychosomatic field should know mechanisms, epidemiology, and management of these common and well-recognized adverse effects of newer antidepressants. Therefore it will be helpful to recognize easily and treat well for patients with psychiatric disorder and psychosomatic disorder using newer antidepressants.
		                        		
		                        		
		                        		
		                        			Antidepressive Agents
		                        			;
		                        		
		                        			Chronic Pain
		                        			;
		                        		
		                        			Citalopram
		                        			;
		                        		
		                        			Dopamine
		                        			;
		                        		
		                        			Epidemiology*
		                        			;
		                        		
		                        			Fibromyalgia
		                        			;
		                        		
		                        			Fluvoxamine
		                        			;
		                        		
		                        			Headache
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Nausea*
		                        			;
		                        		
		                        			Norepinephrine
		                        			;
		                        		
		                        			Psychiatry
		                        			;
		                        		
		                        			Psychophysiologic Disorders
		                        			;
		                        		
		                        			Serotonin
		                        			;
		                        		
		                        			Sertraline
		                        			;
		                        		
		                        			Treatment Failure
		                        			;
		                        		
		                        			Vomiting*
		                        			;
		                        		
		                        			Weight Gain*
		                        			
		                        		
		                        	
6.Electroacupuncture on PC6 prevents opioid-induced nausea and vomiting after laparoscopic surgery.
Siwoo LEE ; Myeong Soo LEE ; Deok Hwa CHOI ; Su Kyung LEE
Chinese journal of integrative medicine 2013;19(4):277-281
OBJECTIVETo investigate the treatment time dependence of electroacupuncture (EA) on Neiguan (PC6) for preventing postoperative nausea and vomiting (PONV).
METHODSOne hundred and seventy-eight patients, who had received intravenous patient-controlled analgesia (PCA) with Fentanyl, were assigned randomly to three groups using random numbers: a pre-operative EA group (PrEA), a post-operative EA group (PoEA), and a non-acupuncture control group (NC). An anesthetist evaluated the incidence and severity of nausea and vomiting for 48 h after surgery blindly. The main outcomes were severity and freguency of PONV, which were measured with a self-reported questionnaire and a confirmation from the anesthetist. The data were analyzed with ANOVA and Z-test.
RESULTSThe incidence of nausea and vomiting was significantly lower in the PrEA group than the NC group during 48 h after surgery (P<0.01, P<0.05). The incidence of vomiting was also significantly lower in the PrEA group than the PoEA group (P<0.05). The PoEA subjects evidenced no significant differences compared with the NC subjects in terms of the incidence of nausea and vomiting (P<0.05). The severity of nausea was significantly lower in the PrEA group than in the NC and PoEA groups (P<0.05).
CONCLUSIONSEA on PC6 is effective in the prevention of PONV, and pre-operative acupuncture is more effective than post-operative acupuncture.
Acupuncture Points ; Adult ; Analgesics, Opioid ; adverse effects ; Electroacupuncture ; Female ; Humans ; Incidence ; Laparoscopy ; adverse effects ; Male ; Middle Aged ; Postoperative Nausea and Vomiting ; epidemiology ; etiology ; prevention & control
7.Concomitant Functional Gastrointestinal Symptoms Influence Psychological Status in Korean Migraine Patients.
Jeong Wook PARK ; Young Seok CHO ; Soo Yeon LEE ; Eun Sun KIM ; Hyunjung CHO ; Hae Eun SHIN ; Gyoung Im SUH ; Myung Gyu CHOI
Gut and Liver 2013;7(6):668-674
		                        		
		                        			
		                        			BACKGROUND/AIMS: Migraine is frequently accompanied by symptoms consistent with functional gastrointestinal disorders (FGIDs). This study evaluated the prevalence of functional gastrointestinal symptoms and assessed the symptoms' relationship with the concomitant functional symptoms of anxiety, depression, and headache-related disability. METHODS: This prospective study included 109 patients with migraine who were recruited from a headache clinic at a teaching hospital. The participants completed a self-administered survey that collected information on headache characteristics, functional gastrointestinal symptoms (using Rome III criteria to classify FGID), anxiety, depression, and headache-related disability. RESULTS: In total, 71% of patients met the Rome III criteria for at least one FGID. In patients with FGID, irritable bowel syndrome was the most common symptom (40.4%), followed by nausea and vomiting syndrome (24.8%) and functional dyspepsia (23.9%). Depression and anxiety scores were significantly higher in patients meeting the criteria for any FGID. The number of the symptoms consistent with FGID in individual patients correlated positively with depression and anxiety. CONCLUSIONS: FGID symptoms defined by the Rome III criteria are highly prevalent in migraine. These symptoms correlate with psychological comorbidities, such as depression and anxiety.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Anxiety/epidemiology/psychology
		                        			;
		                        		
		                        			Comorbidity
		                        			;
		                        		
		                        			Depression/epidemiology/psychology
		                        			;
		                        		
		                        			Disability Evaluation
		                        			;
		                        		
		                        			Dyspepsia/epidemiology/psychology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gastrointestinal Diseases/*epidemiology/*psychology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Migraine Disorders/*epidemiology/*psychology
		                        			;
		                        		
		                        			Nausea/epidemiology/psychology
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Vomiting/epidemiology/psychology
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
8.The Prevalence of Gastrointestinal Symptoms in Patients with Non-Insulin Dependent Diabetes Mellitus.
Jung Hwan OH ; Myung Gyu CHOI ; Moo Il KANG ; Kang Moon LEE ; Jin Il KIM ; Byung Wook KIM ; Dong Soo LEE ; Sung Soo KIM ; Hwang CHOI ; Sok Won HAN ; Kyu Yong CHOI ; Ho Young SON ; In Sik CHUNG
The Korean Journal of Internal Medicine 2009;24(4):309-317
		                        		
		                        			
		                        			BACKGROUND/AIMS: Gastrointestinal (GI) symptoms are common among patients with non-insulin dependent diabetes mellitus (NIDDM). Our aim was to investigate the frequency of chronic GI symptoms in Korean patients with NIDDM. METHODS: A cross-sectional survey, using a reliable and valid questionnaire, was performed in diabetes clinics from seven hospitals of the Catholic University of Korea. RESULTS: A total of 608 patients (249 males and 359 females, mean age 53.7+/-10.9 years) were investigated. The frequencies of weekly heartburn and acid regurgitation (esophageal symptoms) were 7.1% (95% confidence interval [CI], 5.0 to 9.2) and 4.4% (95% CI, 2.8 to 6.1), respectively. The frequency of dyspepsia was 13.2% (95% CI, 10.5 to 15.8). The frequencies of constipation and diarrhea were 15.0% (95% CI, 12.2 to 18.0) and 5.3% (95% CI, 3.5 to 7.1), respectively. Nausea and the use of manual maneuvers to facilitate defecation were more prevalent in women than in men. Constipation and fecal incontinence were more common in diabetes patients with long duration (>10 years). Fecal incontinence and using laxatives were more frequent in the complicated diabetes group. Using laxatives was more frequent in the uncontrolled diabetes group. CONCLUSIONS: Two-thirds of diabetic patients experienced GI symptoms. The prevalence of GI symptoms was more common in patients who had diabetic complications and a long duration of diabetes.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Constipation/epidemiology
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/*complications
		                        			;
		                        		
		                        			Dyspepsia/epidemiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gastrointestinal Diseases/*epidemiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Nausea/epidemiology
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Sex Characteristics
		                        			;
		                        		
		                        			Vomiting/epidemiology
		                        			
		                        		
		                        	
9.Evaluation of transcutaneous electroacupoint stimulation with the train-of-four mode for preventing nausea and vomiting after laparoscopic cholecystectomy.
Yu-yong LIU ; Shan-e DUAN ; Ming-xue CAI ; Peng ZOU ; Yong LAI ; Ya-lan LI
Chinese journal of integrative medicine 2008;14(2):94-97
OBJECTIVETo evaluate the efficacy of transcutaneous electroacupoint stimulation with a train-of-four (TOF) mode for the prevention of postoperative nausea and vomiting (PONV) in the patients undergoing laparoscopic cholecystectomy.
METHODSNinety-six ASA Grade I - II patients scheduled for laparoscopic cholecystectomy were randomized into Neiguan (P6) electroacupoint stimulation group (treated group) and a placebo control group (placement of electrodes without electroacupoint stimulation). The anesthetic regimen was standardized by needling at Neiguan on the left side and connecting the TOF peripheral nerve stimulator. The incidence of nausea, vomiting, severity, antiemetic dosage and the degree of pain were assessed at 0, 60, 120 min, and 24 h after surgery.
RESULTSThe incidence of nausea and vomiting, the dose of antiemetics and the occurrence of severe nausea were all significantly lower in the treated group compared with the control group and the score for pain was obviously reduced in patients of the treated group at 24 h post-operation (P<0.05 or P<0.01).
CONCLUSIONTranscutaneous electroacupoint stimulation at P6 with the TOF mode could reduce the incidence and severity of nausea and vomiting with analgesic effects.
Acupuncture Points ; Adult ; Antiemetics ; therapeutic use ; China ; epidemiology ; Cholecystectomy, Laparoscopic ; adverse effects ; Female ; Humans ; Incidence ; Intraoperative Period ; Male ; Pain ; pathology ; Postoperative Nausea and Vomiting ; drug therapy ; epidemiology ; prevention & control ; Transcutaneous Electric Nerve Stimulation ; methods
10.Clinical Characteristics of Adult Patients with Acute Hepatitis A.
Jong Ryul EUN ; Heon Ju LEE ; Tae Nyeun KIM ; Byung Ik JANG ; Hee Jung MOON
Yeungnam University Journal of Medicine 2007;24(2):170-178
		                        		
		                        			
		                        			BACKGROUND: The incidence of acute hepatitis A in adults has recently been increasing. This study was conducted to investigate the epidemiology and clinical characteristics of acute hepatitis A in Daegu province over the past 10 years. MATERIALS AND METHODS: We reviewed the medical records of 55 patients (male/female: 34/21), who were diagnosed with acute hepatitis A by confirmation of the IgM anti-HAV between January 1998 and June 2007. RESULTS: The mean age was 29.7+/-10.3 years (range; 17-65 years). The incidence was most common between March and June (56.1%), in the third and fourth decades of life (78.2%) and 90.9% (50/55) of the patients were diagnosed from 2003 to present. The common symptoms included anorexia, nausea or vomiting (69.1%), fever and chills (49.1%), myalgia (47.3%), weight loss (47.3%), fatigue (40.0%), abdominal pain (36.4%), diarrhea (9.1%) and pruritus (5.5%). The mean duration of hospital stay was 8.6+/-3.4 days (range; 3-20 days). The route of transmission was identified in only 11 patients (20.0%); 7 patients (12.7%) traveled (abroad or domestic), 2 patients (3.6%) ingested raw food and 2 patients (3.6%) had friends with acute hepatitis A. Fifty four patients recovered without complication; one patient developed fulminant hepatitis and recovered after a liver transplantation. CONCLUSION: The incidence of acute hepatitis A in adults is increasing. Because of the cost of treatment and potential for serious disease, persons, under 40 are recommened to have hepatitis A vaccination and confirmation of IgG anti-HAV.
		                        		
		                        		
		                        		
		                        			Abdominal Pain
		                        			;
		                        		
		                        			Adult*
		                        			;
		                        		
		                        			Anorexia
		                        			;
		                        		
		                        			Chills
		                        			;
		                        		
		                        			Daegu
		                        			;
		                        		
		                        			Diarrhea
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Fatigue
		                        			;
		                        		
		                        			Fever
		                        			;
		                        		
		                        			Friends
		                        			;
		                        		
		                        			Hepatitis A Antibodies
		                        			;
		                        		
		                        			Hepatitis A virus
		                        			;
		                        		
		                        			Hepatitis A*
		                        			;
		                        		
		                        			Hepatitis*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulin G
		                        			;
		                        		
		                        			Immunoglobulin M
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Length of Stay
		                        			;
		                        		
		                        			Liver Transplantation
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Myalgia
		                        			;
		                        		
		                        			Nausea
		                        			;
		                        		
		                        			Pruritus
		                        			;
		                        		
		                        			Vaccination
		                        			;
		                        		
		                        			Vomiting
		                        			;
		                        		
		                        			Weight Loss
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail